Remicade and Rhonchi - a phase IV clinical study of FDA data

Summary:

Rhonchi is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Methotrexate, and have High blood pressure.

The phase IV clinical study analyzes which people have Rhonchi when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Rhonchi?

Rhonchi (abnormal breath sounds) is found to be associated with 484 drugs and 466 conditions by eHealthMe. Check the latest studies of Rhonchi.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 20 people (0.01%) have Rhonchi.

Among these 20 people:

How long have people been on Remicade when they have Rhonchi? *

What is the gender of people who have Rhonchi when taking Remicade? *

female: 65 %
male: 35 %

What is the age of people who have Rhonchi when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Rhonchi? *

Dyspnea (difficult or laboured breathing): 7 people, 35.00%
Chest Pain: 6 people, 30.00%
Back Pain: 6 people, 30.00%
Infusion Related Reaction: 5 people, 25.00%
Fatigue (feeling of tiredness): 5 people, 25.00%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 20.00%
Rashes (redness): 4 people, 20.00%
Rales (an abnormal respiratory sound characterized by fine crackles): 4 people, 20.00%
Fever: 3 people, 15.00%
Hypotension (abnormally low blood pressure): 3 people, 15.00%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 10.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.00%
Hidradenitis (chronic disease of a type of sweat gland): 1 person, 5.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 5.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 5.00%
Diabetes: 1 person, 5.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Rhonchi?

- Check whether Rhonchi is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Rhonchi treatments and more:

Rhonchi (2,421 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rhonchi:

Rhonchi (484 drugs)

Browse all the conditions that are associated with Rhonchi:

Rhonchi (466 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.